[go: up one dir, main page]

AUPR526401A0 - Amplification of the oral delivery of growth hormone using polymers - Google Patents

Amplification of the oral delivery of growth hormone using polymers

Info

Publication number
AUPR526401A0
AUPR526401A0 AUPR5264A AUPR526401A AUPR526401A0 AU PR526401 A0 AUPR526401 A0 AU PR526401A0 AU PR5264 A AUPR5264 A AU PR5264A AU PR526401 A AUPR526401 A AU PR526401A AU PR526401 A0 AUPR526401 A0 AU PR526401A0
Authority
AU
Australia
Prior art keywords
amplification
polymers
growth hormone
oral delivery
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR5264A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Access Pharmaceuticals Australia Pty Ltd
Original Assignee
Biotech Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd filed Critical Biotech Australia Pty Ltd
Priority to AUPR5264A priority Critical patent/AUPR526401A0/en
Publication of AUPR526401A0 publication Critical patent/AUPR526401A0/en
Assigned to ACCESS PHARMACEUTICALS AUSTRALIA PTY LIMITED reassignment ACCESS PHARMACEUTICALS AUSTRALIA PTY LIMITED Assignment by Applicant under S 113 Assignors: BIOTECH AUSTRALIA PTY LIMITED
Assigned to ACCESS PHARMACEUTICALS AUSTRALIA PTY LIMITED reassignment ACCESS PHARMACEUTICALS AUSTRALIA PTY LIMITED Alteration of Name(s) of Applicant(s) under S113 Assignors: BIOTECH AUSTRALIA PTY LIMITED
Abandoned legal-status Critical Current

Links

AUPR5264A 2001-05-25 2001-05-25 Amplification of the oral delivery of growth hormone using polymers Abandoned AUPR526401A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AUPR5264A AUPR526401A0 (en) 2001-05-25 2001-05-25 Amplification of the oral delivery of growth hormone using polymers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR5264A AUPR526401A0 (en) 2001-05-25 2001-05-25 Amplification of the oral delivery of growth hormone using polymers

Publications (1)

Publication Number Publication Date
AUPR526401A0 true AUPR526401A0 (en) 2001-06-21

Family

ID=3829242

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR5264A Abandoned AUPR526401A0 (en) 2001-05-25 2001-05-25 Amplification of the oral delivery of growth hormone using polymers

Country Status (1)

Country Link
AU (1) AUPR526401A0 (en)

Similar Documents

Publication Publication Date Title
AU2002342653A1 (en) Modified growth hormone
AU2002330273A1 (en) Liposome-encapsulated insulin formulations
AU2002246925A1 (en) Therapeutic delivery balloon
AU2002248464A1 (en) Stabilized insulin formulations
AU2002341959A1 (en) Drug delivery devices and methods
AU2002363998A1 (en) Bioadhesive drug delivery system with enhanced gastric retention
AU2002319653A1 (en) Method for oral drug delivery
AUPR621501A0 (en) Delivery of ds rna
AU2002352344A1 (en) Medicament delivery assembly
AU2001270206A1 (en) Dental implant
AU2002343555A1 (en) Eutectic-based self-nanoemulsified drug delivery system
AU2002253039A1 (en) Tramadol-based medicament
AU2002352410A1 (en) Improved oral medicine dispenser
AU2002258221A1 (en) Medicinal composition
AU2002329959A1 (en) Stable dental analog systems
AU2002210298A1 (en) Dental implant
AU2002308649A1 (en) Compositions and methods for enhancing drug delivery
AU3926000A (en) Methods and compositions for drug delivery
AUPR526401A0 (en) Amplification of the oral delivery of growth hormone using polymers
AUPS254002A0 (en) Amplification of the oral delivery of growth hormone using polymers
AU2002354460A1 (en) Medicinal composition
AU2001244854A1 (en) Local drug delivery
AU2003902676A0 (en) Amplification of the oral delivery of growth hormone using polymers
AU2002350181A1 (en) Compositions and methods for viral delivery
AU2002315287A1 (en) Pharmaceutical composition comprising clavulanic acid

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: ACCESS PHARMACEUTICALS AUSTRALIA PTY. LTD.

Free format text: THE FORMER OWNER WAS: BIOTECH AUSTRALIA PTY. LIMITED